Alere Inc. accused Abbott Laboratories of seeking to scuttle the health-care companies' $5.8 billion merger by failing to get antitrust clearance because of "buyer's remorse," according to a newly unsealed lawsuit. Abbott Chief Executive Officer Miles White vowed in a meeting with Alere's top executives...